The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis
Open accessAbstract
Abstract Rationale Understanding the role of the airway microbiome in chronic obstructive pulmonary disease (COPD) inflammatory endotypes may help to develop microbiome-based diagnostic and therapeutic approaches. Objectives To understand the association of the airway microbiome with neutrophilic and eosinophilic COPD at stability and during exacerbations. Methods An integrative analysis was performed on 1,706 sputum samples collected longitudinally from 510 patients with COPD recruited at four UK sites of the BEAT-COPD (Biomarkers to Target Antibiotic and Systemic COPD), COPDMAP (Chronic Obstructive Pulmonary Disease Medical Research Council/Association of the British Pharmaceutical Industry), and AERIS (Acute Exacerbation and Respiratory Infections in COPD) cohorts. The microbiome was analyzed using COPDMAP and AERIS as a discovery data set and BEAT-COPD as a validation data set. Measurements and Main Results The airway microbiome in neutrophilic COPD was heterogeneous, with two primary community types differentiated by the predominance of Haemophilus. The Haemophilus-predominant subgroup had elevated sputum IL-1β and TNFα (tumor necrosis factor α) and was relatively stable over time. The other neutrophilic subgroup with a balanced microbiome profile had elevated sputum and serum IL-17A and was temporally dynamic. Patients in this state at stability were susceptible to the greatest microbiome shifts during exacerbations. This subgroup can temporally switch to both neutrophilic Haemophilus-predominant and eosinophilic states that were otherwise mutually exclusive. Time-series analysis on the microbiome showed that the temporal trajectories of Campylobacter and Granulicatella were indicative of intrapatient switches from neutrophilic to eosinophilic inflammation, in track with patient sputum eosinophilia over time. Network analysis revealed distinct host–microbiome interaction patterns among neutrophilic Haemophilus-predominant, neutrophilic balanced microbiome, and eosinophilic subgroups. Conclusions The airway microbiome can stratify neutrophilic COPD into subgroups that justify different therapies. Neutrophilic and eosinophilic COPD are interchangeable in some patients. Monitoring temporal variability of the airway microbiome may track patient inflammatory status over time.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DADA2: High–resolution sample inference from Illumina amplicon data
Callahan, B. J., McMurdie, P. J., Rosen, M. J., Han, A. W., Johnson, A. J. A., & Holmes, S. P. (2016) · Nature Methods · doi:10.1038/nmeth.3869 · Cited by 35,698 · cited 2×
“The demultiplexed sequencing reads were denoised to generate amplicon sequence variants using DADA2 (Divisive Amplicon Denoising Algorithm 2) (28).”
MethodReproducible, interactive, scalable and extensible microbiome data science using QIIME 2
Bolyen, E., Rideout, J. R., Dillon, M. R., Bokulich, N. A., Abnet, C. C., Al-Ghalith, G. A., Alexander, H., Alm, E. J., Arumugam, M., Asnicar, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0209-9 · Cited by 23,742
Gephi: An Open Source Software for Exploring and Manipulating Networks
Bastian, M., Heymann, S., & Jacomy, M. (2009) · Proceedings of the International AAAI Conference on Web and Social Media · doi:10.1609/icwsm.v3i1.13937 · Cited by 11,675 · cited 2×
“Amicrobiome cooccurrence network was established using SparCC (Sparse Correlations for Compositional data) (36) and visualized using Gephi (37).”
MethodInfluentialAdjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Enterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., Andrews, E., Ajami, N. J., Bonham, K. S., Brislawn, C. J., et al. (2019) · Nature · doi:10.1038/s41586-019-1237-9 · Cited by 3,143 · cited 1×
“The correlation between microbiome genera and mediators was assessed first by residualization using a general linear mixed model to adjust for demographic covariates and then by hierarchical all-against-all association testing using HAllA (Hierarchical All-against-All association testing) (38).”
MethodJacomy, M., Venturini, T., Heymann, S., & Bastian, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098679 · Cited by 2,909
Inferring Correlation Networks from Genomic Survey Data
Friedman, J., & Alm, E. J. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002687 · Cited by 2,706
Optimal Detection of Changepoints With a Linear Computational Cost
Killick, R., Fearnhead, P., & Eckley, I. A. (2012) · Journal of the American Statistical Association · doi:10.1080/01621459.2012.737745 · Cited by 2,548
Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary Disease
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P. W., HERSHFIELD, E. S., HARDING, G. K. M., & NELSON, N. A. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-2-196 · Cited by 2,492
Temporal Dynamics of the Human Vaginal Microbiota
Gajer, P., Brotman, R. M., Bai, G., Sakamoto, J., Schütte, U. M. E., Zhong, X., Koenig, S. S. K., Fu, L., Ma, Z. (., Zhou, X., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003605 · Cited by 1,558
Chronic obstructive pulmonary disease: current burden and future projections
Lopez, A. D., Shibuya, K., Rao, C., Mathers, C. D., Hansell, A. L., Held, L. S., Schmid, V., & Buist, S. (2006) · European Respiratory Journal · doi:10.1183/09031936.06.00025805 · Cited by 1,335
changepoint : An R Package for Changepoint Analysis
Killick, R., & Eckley, I. A. (2014) · Journal of Statistical Software · doi:10.18637/jss.v058.i03 · Cited by 1,330 · cited 1×
“Changepoint detection analysis was performed using the pruned exact linear time algorithm (33) in the changepoint package in R (R Foundation for Statistical Computing) (34) to search for temporal change points on the relative abundance of microbiome genera.”
MethodCharacterisation of COPD heterogeneity in the ECLIPSE cohort
the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators, Agusti, A., Calverley, P. M., Celli, B., Coxson, H. O., Edwards, L. D., Lomas, D. A., MacNee, W., Miller, B. E., Rennard, S., et al. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-122 · Cited by 1,157
Self-citationBafadhel, M., McKenna, S., Terry, S., Mistry, V., Reid, C., Haldar, P., McCormick, M., Haldar, K., Kebadze, T., Duvoix, A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201104-0597oc · Cited by 1,094
Self-citationToward a Consensus Definition for COPD Exacerbations
Rodriguez-Roisin, R. (2000) · Chest · doi:10.1378/chest.117.5_suppl_2.398s · Cited by 969
Inflammatory subtypes in asthma: Assessment and identification using induced sputum
SIMPSON, J. L., SCOTT, R., BOYLE, M. J., & GIBSON, P. G. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00784.x · Cited by 955
Busse, W. W., Holgate, S., Kerwin, E., Chon, Y., Feng, J., Lin, J., & Lin, S.-L. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2318oc · Cited by 666
The Role of Lung and Gut Microbiota in the Pathology of Asthma
Barcik, W., Boutin, R. C. T., Sokolowska, M., & Finlay, B. B. (2020) · Immunity · doi:10.1016/j.immuni.2020.01.007 · Cited by 613
Brightling, C. E., Monteiro, W., Ward, R., Parker, D., Morgan, M. D., Wardlaw, A. J., & Pavord, I. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02872-5 · Cited by 595
Self-citationThe Lung Tissue Microbiome in Chronic Obstructive Pulmonary Disease
Sze, M. A., Dimitriu, P. A., Hayashi, S., Elliott, W. M., McDonough, J. E., Gosselink, J. V., Cooper, J., Sin, D. D., Mohn, W. W., & Hogg, J. C. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201111-2075oc · Cited by 552
Clarithromycin Targets Neutrophilic Airway Inflammation in Refractory Asthma
Simpson, J. L., Powell, H., Boyle, M. J., Scott, R. J., & Gibson, P. G. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200707-1134oc · Cited by 482
Exacerbations of chronic obstructive pulmonary disease
Celli, B. R., & Barnes, P. J. (2007) · European Respiratory Journal · doi:10.1183/09031936.00109906 · Cited by 462
Lung microbiome dynamics in COPD exacerbations
Wang, Z., Bafadhel, M., Haldar, K., Spivak, A., Mayhew, D., Miller, B. E., Tal-Singer, R., Johnston, S. L., Ramsheh, M. Y., Barer, M. R., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.01406-2015 · Cited by 459
Self-citationT H 2 and T H 17 inflammatory pathways are reciprocally regulated in asthma
Choy, D. F., Hart, K. M., Borthwick, L. A., Shikotra, A., Nagarkar, D. R., Siddiqui, S., Jia, G., Ohri, C. M., Doran, E., Vannella, K. M., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab3142 · Cited by 450 · cited 1×
“The biology underlying this dynamism is uncertain, but it has been shown that therapeutic blockade of Th2 cytokines enhances Th17 inflammation in asthma (49), suggesting that ICS treatment may contribute to the endotypic switches.”
BackgroundDurack, J., Lynch, S. V., Nariya, S., Bhakta, N. R., Beigelman, A., Castro, M., Dyer, A.-M., Israel, E., Kraft, M., Martin, R. J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.08.055 · Cited by 320
Taylor, S. L., Leong, L. E. X., Choo, J. M., Wesselingh, S., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Jenkins, C., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.03.044 · Cited by 314
Inflammatory endotypes in COPD
Barnes, P. J. (2019) · Allergy · doi:10.1111/all.13760 · Cited by 313
Bach, P. B., Brown, C., Gelfand, S. E., & McCrory, D. C. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00016 · Cited by 287
Mayhew, D., Devos, N., Lambert, C., Brown, J. R., Clarke, S. C., Kim, V. L., Magid-Slav, M., Miller, B. E., Ostridge, K. K., Patel, R., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-210408 · Cited by 285
Self-citationThe sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease
Dicker, A. J., Huang, J. T. J., Lonergan, M., Keir, H. R., Fong, C. J., Tan, B., Cassidy, A. J., Finch, S., Mullerova, H., Miller, B. E., et al. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.02.040 · Cited by 230
Self-citationCOPD exacerbations {middle dot} 3: Pathophysiology
O'Donnell, D. E. (2006) · Thorax · doi:10.1136/thx.2005.041830 · Cited by 207
Airway dysbiosis:Haemophilus influenzae and Tropheryma in poorly controlled asthma
Simpson, J. L., Daly, J., Baines, K. J., Yang, I. A., Upham, J. W., Reynolds, P. N., Hodge, S., James, A. L., Hugenholtz, P., Willner, D., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.00405-2015 · Cited by 204
Understanding the role of neutrophils in chronic inflammatory airway disease
Jasper, A. E., McIver, W. J., Sapey, E., & Walton, G. M. (2019) · F1000Research · doi:10.12688/f1000research.18411.1 · Cited by 187
Segal, L. N., Clemente, J. C., Wu, B. G., Wikoff, W. R., Gao, Z., Li, Y., Ko, J. P., Rom, W. N., Blaser, M. J., & Weiden, M. D. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208599 · Cited by 176
Chen, K., Pociask, D. A., McAleer, J. P., Chan, Y. R., Alcorn, J. F., Kreindler, J. L., Keyser, M. R., Shapiro, S. D., Houghton, A. M., Kolls, J. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020333 · Cited by 167
Inflammation-associated microbiota in pediatric eosinophilic esophagitis
Benitez, A. J., Hoffmann, C., Muir, A. B., Dods, K. K., Spergel, J. M., Bushman, F. D., & Wang, M.-L. (2015) · Microbiome · doi:10.1186/s40168-015-0085-6 · Cited by 162
Correcting for batch effects in case-control microbiome studies
Gibbons, S. M., Duvallet, C., & Alm, E. J. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006102 · Cited by 162
Wang, Z., Singh, R., Miller, B. E., Tal‐Singer, R., Horn, S. V., Tomsho, L., Mackay, A. J., Allinson, J. P., Webb, A. J., Brookes, A. J., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2017-210741 · Cited by 158
Self-citationBlood and sputum eosinophils in COPD; relationship with bacterial load
Kolsum, U., Donaldson, G. C., Singh, R., Barker, B. L., Gupta, V., George, L., Webb, A. J., Thurston, S., Brookes, A. J., McHugh, T. D., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0570-5 · Cited by 144
Self-citationGhebre, M. A., Bafadhel, M., Desai, D., Cohen, E. S., Newbold, P., Rapley, L., Woods, J., Rugman, P., Pavord, I. D., Newby, C., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.035 · Cited by 140
Self-citationBlood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease
Singh, D., Bafadhel, M., Brightling, C. E., Sciurba, F. C., Curtis, J. L., Martínez, F. J., Pasquale, C. B., Merrill, D. D., Metzdorf, N., Petruzzelli, S., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201912-2384pp · Cited by 124
Self-citationTh17 cytokines: novel potential therapeutic targets for COPD pathogenesis and exacerbations
Rouzic, O. L., Pichavant, M., Fréalle, É., Guillon, A., Si‐Tahar, M., & Gosset, P. (2017) · European Respiratory Journal · doi:10.1183/13993003.02434-2016 · Cited by 120
Roos, A. B., Sethi, S., Nikota, J. K., Wrona, C. T., Dorrington, M. G., Sandén, C., Bauer, C. M. T., Shen, P., Bowdish, D. M. E., Stevenson, C. S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201409-1689oc · Cited by 119
Christenson, S. A., van den Berge, M., Faiz, A., Inkamp, K., Bhakta, N. R., Bonser, L. R., Zlock, L. T., Barjaktarević, I., Barr, R. G., Bleecker, E. R., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121087 · Cited by 117
Durack, J., Christian, L. S., Nariya, S., Gonzalez, J. R., Bhakta, N. R., Ansel, K. M., Beigelman, A., Castro, M., Dyer, A., Israel, E., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.03.028 · Cited by 104
Eosinophils in infection and intestinal immunity
Hogan, S. P., Waddell, A., & Fulkerson, P. C. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835ab29a · Cited by 99
Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort
Kim, V. L., Coombs, N. A., Staples, K. J., Ostridge, K., Williams, N. P., Wootton, S. A., Devaster, J., Aris, E., Clarke, S. C., Tuck, A. C., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00853-2017 · Cited by 96
Self-citationIL-17 in lung disease: friend or foe?
Tan, H., & Rosenthal, M. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203307 · Cited by 91
Layeghifard, M., Li, H., Wang, P. W., Donaldson, S. L., Coburn, B. A., Clark, S. T., Caballero, J. D., Zhang, Y., Tullis, D. E., Yau, Y. C. W., et al. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0077-y · Cited by 84
Singh, R., Mackay, A. J., Patel, A. R. C., Garcha, D. S., Kowlessar, B. S., Brill, S., Donnelly, L., Barnes, P. J., Donaldson, G. C., & Wedzicha, J. A. (2014) · Respiratory Research · doi:10.1186/s12931-014-0114-1 · Cited by 78
Self-citationTargeting Chronic Obstructive Pulmonary Disease Phenotypes, Endotypes, and Biomarkers
Garudadri, S., & Woodruff, P. G. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201808-533mg · Cited by 76
Serum Amyloid A Promotes Lung Neutrophilia by Increasing IL-17A Levels in the Mucosa and γδ T Cells
Anthony, D., Seow, H. J., Uddin, M., Thompson, M. A., Dousha, L. F., Vlahos, R., Irving, L. B., Levy, B. D., Anderson, G. P., & Bozinovski, S. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201211-2139oc · Cited by 72
Asthma Microbiome Studies and the Potential for New Therapeutic Strategies
Huang, Y. J. (2013) · Current Allergy and Asthma Reports · doi:10.1007/s11882-013-0355-y · Cited by 70
Sputum microbiota in moderateversussevere patients with COPD
Galiana, A., Aguirre, E., Rodríguez, J. C., Mira, Á., Santibáñez, M., Candela, I., Llavero, J., Garcinuño, P., Martínez-López, F. J., Ruiz, M., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00191513 · Cited by 68
Millares, L., Pascual-Guàrdia, S., Montón, C., García-Núñez, M., Lalmolda, C., Faner, R., Casadevall, C., Setó, L., Capilla, S., Moreno, A., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0867-x · Cited by 62
Macrolide antibiotics and asthma treatment
Johnston, S. L. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.03.035 · Cited by 53
Diver, S. E., Richardson, M., Haldar, K., Ghebre, M. A., Ramsheh, M. Y., Bafadhel, M., Desai, D., Cohen, E. S., Newbold, P., Rapley, L., et al. (2019) · Allergy · doi:10.1111/all.14058 · Cited by 50
Self-citationRoca, J., Vargas, C., Cano, I., Selivanov, V. A., Barreiro, E., Maier, D., Falciani, F., Wagner, P. D., Cascante, M., García‐Aymerich, J., et al. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-s2-s3 · Cited by 48
Tufvesson, E., Bjermer, L. H., & Ekberg, M. (2015) · International Journal of COPD · doi:10.2147/copd.s78748 · Cited by 44
Meeting the Challenge of Identifying New Treatments for Type 2-Low Neutrophilic Asthma
Kalchiem‐Dekel, O., Yao, X., & Levine, S. J. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.08.2192 · Cited by 41
Couderc, E., Morel, F., Levillain, P., Buffière-Morgado, A., Camus, M., Paquier, C., Bodet, C., Jégou, J., Pohin, M., Favot, L., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181486 · Cited by 31
Stability of eosinophilic inflammation in COPD bronchial biopsies
Higham, A., Leow‐Dyke, S., Jackson, N. A., & Singh, D. (2020) · European Respiratory Journal · doi:10.1183/13993003.00622-2020 · Cited by 24
Self-citation
Cited by
Chronic obstructive pulmonary disease
Christenson, S. A., Smith, B. M., Bafadhel, M., & Putcha, N. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00470-6 · Cited by 1,219
Self-citationTowards the elimination of chronic obstructive pulmonary disease: a Lancet Commission
Stolz, D., Mkorombindo, T., Schumann, D. M., Agusti, A., Ash, S. Y., Bafadhel, M., Bai, C., Chalmers, J. D., Criner, G. J., Dharmage, S. C., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01273-9 · Cited by 681
Self-citationThe dynamic lung microbiome in health and disease
Natalini, J. G., Singh, S., & Segal, L. N. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00821-x · Cited by 523
Lung microbiome: new insights into the pathogenesis of respiratory diseases
Li, R., Li, J., & Zhou, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01722-y · Cited by 434
Metadata
- Authors
- Wang, Z., Locantore, N., Haldar, K., Ramsheh, M. Y., Beech, A. S., Ma, W., Brown, J. R., Tal-Singer, R., Barer, M. R., Bafadhel, M., Donaldson, G. C., Wedzicha, J. A., Singh, D., Wilkinson, T. M. A., Miller, B. E., & Brightling, C. E.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-06-15
- Volume
- 203
- Issue
- 12
- Pages
- 1488-1502
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3112183009
- Cited by
- 274
- References
- 63
- FWCI
- 11.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.